Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases
B Shriyan, D Patil, M Gurjar, M Nookala, A Patil… - European Journal of …, 2020 - Springer
Purpose Patients of non–small cell lung cancer (NSCLC) with brain metastases have limited
treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in the past …
treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in the past …
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non-small cell lung cancer (NSCLC) with brain metastases
B Shriyan, D Patil, M Gurjar… - … journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose Patients of non-small cell lung cancer (NSCLC) with brain metastases have limited
treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in the past …
treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in the past …
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases.
B Shriyan, D Patil, M Gurjar… - … Journal of Clinical …, 2020 - search.ebscohost.com
Purpose: Patients of non–small cell lung cancer (NSCLC) with brain metastases have
limited treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in …
limited treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in …
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases
S Bharati, P Deepali, G Murari… - … Journal of Clinical …, 2020 - search.proquest.com
Purpose Patients of non–small cell lung cancer (NSCLC) with brain metastases have limited
treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in the past …
treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in the past …
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non-small cell lung cancer (NSCLC) with brain metastases.
B Shriyan, D Patil, M Gurjar, M Nookala… - European Journal of …, 2020 - europepmc.org
Purpose Patients of non-small cell lung cancer (NSCLC) with brain metastases have limited
treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in the past …
treatment options. High-dose erlotinib (HDE) and gefitinib (HDG) have been tried in the past …